• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类端粒酶的RNA组分。

The RNA component of human telomerase.

作者信息

Feng J, Funk W D, Wang S S, Weinrich S L, Avilion A A, Chiu C P, Adams R R, Chang E, Allsopp R C, Yu J

机构信息

Geron Corporation, Menlo Park, CA 94025, USA.

出版信息

Science. 1995 Sep 1;269(5228):1236-41. doi: 10.1126/science.7544491.

DOI:10.1126/science.7544491
PMID:7544491
Abstract

Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5'-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG)n. Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.

摘要

真核生物染色体的末端带有重复的端粒序列,这些序列可保护染色体末端免受损伤和重排。端粒重复序列由端粒酶合成,端粒酶是一种核糖核酸(RNA)-蛋白质复合物。本文描述了人类端粒酶RNA组分(称为hTR)的克隆。hTR的模板区域包含11个与人类端粒序列(TTAGGG)n互补的核苷酸(5'-CUAACCCUAAC)。生殖系组织和肿瘤细胞系表达的hTR比正常体细胞和组织更多,而正常体细胞和组织没有可检测到的端粒酶活性。在模板区域发生突变的表达hTR的人类细胞系产生了预测的突变端粒酶活性。用反义hTR转染的HeLa细胞在23至26次倍增后失去端粒DNA并开始死亡。因此,人类端粒酶是永生化肿瘤细胞长期增殖的关键酶。

相似文献

1
The RNA component of human telomerase.人类端粒酶的RNA组分。
Science. 1995 Sep 1;269(5228):1236-41. doi: 10.1126/science.7544491.
2
Functional characterization and developmental regulation of mouse telomerase RNA.小鼠端粒酶RNA的功能表征与发育调控
Science. 1995 Sep 1;269(5228):1267-70. doi: 10.1126/science.7544492.
3
Functional reconstitution of wild-type and mutant Tetrahymena telomerase.野生型和突变型四膜虫端粒酶的功能重建
Genes Dev. 1994 Mar 1;8(5):563-75. doi: 10.1101/gad.8.5.563.
4
Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates.端粒酶的变构抑制剂:3'→5' 磷酰胺寡核苷酸。
Nucleic Acids Res. 2002 Jan 15;30(2):559-68. doi: 10.1093/nar/30.2.559.
5
In vivo and in vitro studies of telomeres and telomerase.端粒与端粒酶的体内和体外研究。
Cold Spring Harb Symp Quant Biol. 1993;58:707-18. doi: 10.1101/sqb.1993.058.01.078.
6
2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.针对人端粒酶RNA的2-5A反义疗法可抑制端粒酶活性并诱导宫颈癌细胞凋亡,而不会损害端粒。
Cancer Gene Ther. 2002 Jul;9(7):624-30. doi: 10.1038/sj.cgt.7700479.
7
TLC1: template RNA component of Saccharomyces cerevisiae telomerase.TLC1:酿酒酵母端粒酶的模板RNA组分。
Science. 1994 Oct 21;266(5184):404-9. doi: 10.1126/science.7545955.
8
[Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].反义人端粒酶RNA与反义人端粒酶催化亚基联合抑制宫颈癌Hela细胞生长
Zhonghua Fu Chan Ke Za Zhi. 2005 Jan;40(1):42-6.
9
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.用人端粒酶模板RNA成分hTR和催化蛋白亚基hTRT重组人端粒酶。
Nat Genet. 1997 Dec;17(4):498-502. doi: 10.1038/ng1297-498.
10
Developmentally programmed healing of chromosomes by telomerase in Tetrahymena.端粒酶在四膜虫中对染色体进行发育编程修复。
Cell. 1991 Nov 15;67(4):823-32. doi: 10.1016/0092-8674(91)90077-c.

引用本文的文献

1
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity.依普黄酮通过上调端粒酶或端粒延长替代途径(ALT)活性来增加人类细胞系中的端粒长度。
Biogerontology. 2025 Sep 4;26(5):178. doi: 10.1007/s10522-025-10315-x.
2
Development of a microarray based telomerase binding assay reveals unusual binding of a cytochalasin derivative.基于微阵列的端粒酶结合检测方法的开发揭示了一种细胞松弛素衍生物的异常结合。
Sci Rep. 2025 Jun 4;15(1):19515. doi: 10.1038/s41598-025-00230-z.
3
Dual synthesis pathways of scaRNA28 via intronic processing of transformation/transcription domain-associated protein transcripts and a novel independent transcription unit.
通过转化/转录结构域相关蛋白转录本的内含子加工以及一个新的独立转录单元产生scaRNA28的双重合成途径。
RNA Biol. 2025 Dec;22(1):1-12. doi: 10.1080/15476286.2025.2513133. Epub 2025 Jun 9.
4
Anticancer Mechanisms of Ginsenoside Compound K: A Review.人参皂苷Compound K的抗癌机制:综述
Diseases. 2025 May 5;13(5):143. doi: 10.3390/diseases13050143.
5
TERT Immunohistochemistry in Thin Melanomas Compared to Melanocytic Nevi.与黑素细胞痣相比,薄黑色素瘤中的端粒酶逆转录酶免疫组织化学
Diagnostics (Basel). 2025 May 4;15(9):1171. doi: 10.3390/diagnostics15091171.
6
Biogenesis and Regulation of Telomerase during Development and Cancer.发育与癌症过程中端粒酶的生物发生及调控
Cold Spring Harb Perspect Biol. 2025 Apr 10. doi: 10.1101/cshperspect.a041692.
7
Metabolic constraint of human telomere length by nucleotide salvage efficiency.核苷酸补救效率对人类端粒长度的代谢限制
Nat Commun. 2025 Mar 27;16(1):3000. doi: 10.1038/s41467-025-58221-7.
8
telomerase RNA: secondary structure and flexible-scaffold function.端粒酶RNA:二级结构与柔性支架功能
bioRxiv. 2025 Feb 23:2025.02.22.638514. doi: 10.1101/2025.02.22.638514.
9
Three- and four-stranded nucleic acid structures and their ligands.三链和四链核酸结构及其配体。
RSC Chem Biol. 2025 Feb 19;6(4):466-491. doi: 10.1039/d4cb00287c. eCollection 2025 Apr 2.
10
Multifunctional molecular hybrid for targeted colorectal cancer cells: Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO.用于靶向结肠直肠癌细胞的多功能分子杂化物:整合阿霉素、AS1411适配体和T9/U4反义寡核苷酸。
PLoS One. 2025 Feb 13;20(2):e0317559. doi: 10.1371/journal.pone.0317559. eCollection 2025.